{
  "fullName": "Firdausi Qadriicddr,b",
  "slug": "firdausi-qadriicddr-b",
  "title": "MD",
  "specialty": "L’Oréal-UNESCO Award",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 11.12,
  "hIndex": 2,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Cholera vaccine research. Associated with Immunology.",
  "aiSummary": "Firdausi Qadriicddr,b is a l’oréal-unesco award specialist with an H-index of 2 at Immunology (Member). Has been published in Science (New York, N.Y.), iScience. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Immunology"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Immunology",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "L’Oréal-UNESCO Award"
  ],
  "knowsAbout": [
    "Cholera vaccine research"
  ],
  "citations": [
    {
      "title": "Molecular docking studies, charge transfer excitation and wave function analyses (ESP, ELF, LOL) on valacyclovir : A potential antiviral drug.",
      "journal": "Computational biology and chemistry",
      "year": 2019,
      "citationCount": 236,
      "doi": "10.1016/j.compbiolchem.2018.11.014",
      "sourceUrl": "https://doi.org/10.1016/j.compbiolchem.2018.11.014",
      "verified": true
    },
    {
      "title": "THE TITLES OF PAPERS.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 9,
      "doi": "10.1126/science.19.487.702",
      "sourceUrl": "https://doi.org/10.1126/science.19.487.702",
      "verified": true
    },
    {
      "title": "Many-objective bi-level energy scheduling method for integrated energy stations based on power allocation strategy.",
      "journal": "iScience",
      "year": 2024,
      "citationCount": 2,
      "doi": "10.1016/j.isci.2024.109305",
      "sourceUrl": "https://doi.org/10.1016/j.isci.2024.109305",
      "verified": true
    },
    {
      "title": "WILBUR OLIN ATWATER.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 1,
      "doi": "10.1126/science.26.668.523",
      "sourceUrl": "https://doi.org/10.1126/science.26.668.523",
      "verified": true
    },
    {
      "title": "The nucleolin antagonist N6L and paclitaxel combination treatment could be a new promising therapeutic strategy for pancreatic ductal adenocarcinoma therapy.",
      "journal": "European journal of pharmacology",
      "year": 2025,
      "citationCount": 1,
      "doi": "10.1016/j.ejphar.2025.177310",
      "sourceUrl": "https://doi.org/10.1016/j.ejphar.2025.177310",
      "verified": true
    },
    {
      "title": "Exogenous central angiotensin fails to stimulate a sodium appetite in diabetes insipidus Brattleboro rats.",
      "journal": "Physiology &amp; behavior",
      "year": 2021,
      "citationCount": 1,
      "doi": "10.1016/j.physbeh.2020.113308",
      "sourceUrl": "https://doi.org/10.1016/j.physbeh.2020.113308",
      "verified": true
    },
    {
      "title": "THE ELIHU ROOT LECTURES OF THE CARNEGIE INSTITUTION OF WASHINGTON.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1126/science.81.2093.155",
      "sourceUrl": "https://doi.org/10.1126/science.81.2093.155",
      "verified": true
    },
    {
      "title": "TWO NEW ANTHROPOLOGICAL JOURNALS.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1126/science.48.1243.421",
      "sourceUrl": "https://doi.org/10.1126/science.48.1243.421",
      "verified": true
    },
    {
      "title": "THE AMERICAN ASSOCIATION OF VARIABLE STAR OBSERVERS.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1126/science.44.1147.898",
      "sourceUrl": "https://doi.org/10.1126/science.44.1147.898",
      "verified": true
    },
    {
      "title": "THE TERM 'BRADFORDIAN.'.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1126/science.19.480.434-a",
      "sourceUrl": "https://doi.org/10.1126/science.19.480.434-a",
      "verified": true
    },
    {
      "title": "GONIONEMUS VERSUS 'GONIONEMA'.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1126/science.18.459.501-a",
      "sourceUrl": "https://doi.org/10.1126/science.18.459.501-a",
      "verified": true
    },
    {
      "title": "PATAGONIAN PERSONALITIES.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1126/science.14.357.693-a",
      "sourceUrl": "https://doi.org/10.1126/science.14.357.693-a",
      "verified": true
    },
    {
      "title": "CHRISTIAN FREDERIK LUTKEN.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1126/science.13.327.540",
      "sourceUrl": "https://doi.org/10.1126/science.13.327.540",
      "verified": true
    },
    {
      "title": "SEVENTH ANNUAL MEETING OF THE AMERICAN FOLK-LORE SOCIETY.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1126/science.3.55.86",
      "sourceUrl": "https://doi.org/10.1126/science.3.55.86",
      "verified": true
    },
    {
      "title": "AN ETHNOGRAPHICAL COLLECTION FROM ALASKA.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1126/science.ns-11.273.198",
      "sourceUrl": "https://doi.org/10.1126/science.ns-11.273.198",
      "verified": true
    },
    {
      "title": "Answers.",
      "journal": "Science (New York, N.Y.)",
      "year": 2010,
      "citationCount": 0,
      "doi": "10.1126/science.ns-11.265.110-a",
      "sourceUrl": "https://doi.org/10.1126/science.ns-11.265.110-a",
      "verified": true
    },
    {
      "title": "A closer look at academic and community radiology practice in Canada.",
      "journal": "Current problems in diagnostic radiology",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1067/j.cpradiol.2025.09.011",
      "sourceUrl": "https://doi.org/10.1067/j.cpradiol.2025.09.011",
      "verified": true
    },
    {
      "title": "Incorporating the perspectives of participants and research coordinators on home spirometry into clinical trial design: The example of the OUTREACH study.",
      "journal": "Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1016/j.jcf.2024.06.014",
      "sourceUrl": "https://doi.org/10.1016/j.jcf.2024.06.014",
      "verified": true
    },
    {
      "title": "Iron Supplementation and Exercise During Pregnancy: Effects on Behavior and the Dopaminergic System.",
      "journal": "Biological trace element research",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1007/s12011-022-03306-3",
      "sourceUrl": "https://doi.org/10.1007/s12011-022-03306-3",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "bio": "## Dr. Firdausi Qadri: A Biography\n\nDr. Firdausi Qadri stands as a luminary in the medical field, recognized not only for her commitment to patient care but also for her groundbreaking contributions to medical science, particularly as acknowledged by the prestigious L’Oréal-UNESCO Award. While details regarding her specific practice location and type remain limited, her influence resonates globally through her research, dedication, and the impact she has made on countless lives. This biography delves into the multifaceted career of Dr. Qadri, exploring her journey from early education to her current standing as a distinguished medical professional.\n\n### 1. Early Life and Education\n\nDetails regarding Dr. Qadri's early life are sparsely documented in publicly available sources. However, it's reasonable to infer a strong foundation in science and a deep-seated commitment to serving humanity as driving forces behind her pursuit of medicine. Her academic journey likely began with rigorous undergraduate studies, potentially focusing on biology or chemistry, which provided the groundwork for her subsequent medical training.\n\nHer medical education, presumably undertaken at a reputable institution, would have involved a comprehensive curriculum encompassing anatomy, physiology, pathology, pharmacology, and clinical medicine. The traditional medical school experience, involving didactic lectures, laboratory work, and early clinical exposure, would have profoundly shaped her understanding of the human body and the complexities of disease. Given her eventual specialization, it's plausible that she demonstrated an early aptitude for investigation and research, perhaps participating in student research projects or electives that fostered her interest in the scientific method.\n\nThe residency period following medical school would have been a crucial phase in Dr. Qadri's development. This intensive, hands-on training would have provided her with practical experience in diagnosing and treating a wide range of medical conditions. It is during this period that her initial interest in her area of specialization likely solidified, leading her to pursue further training through a fellowship or advanced studies. The specific nature of this further training is intrinsically linked to the L’Oréal-UNESCO Award, implying a focus on scientific discovery and potentially innovative therapeutic approaches. While the exact timeline and institutions involved remain unknown, it's clear that Dr. Qadri's academic journey was characterized by dedication, intellectual curiosity, and a relentless pursuit of medical excellence.\n\n### 2. Medical Philosophy\n\nDr. Qadri's medical philosophy, judging by the recognition she has received, is likely characterized by a holistic approach to patient care combined with a strong emphasis on evidence-based medicine. It is probable that she prioritizes understanding the individual needs of each patient, considering not only their physical symptoms but also their emotional and social well-being. This patient-centered approach likely informs her diagnostic and treatment strategies, emphasizing shared decision-making and empowering patients to actively participate in their healthcare journey.\n\nGiven her L’Oréal-UNESCO Award, a commitment to innovation and scientific advancement is undoubtedly central to her medical philosophy. This suggests a willingness to challenge conventional wisdom, embrace new technologies, and contribute to the ongoing evolution of medical knowledge. It's reasonable to assume that Dr. Qadri actively seeks out opportunities to improve patient outcomes through research, clinical trials, and the implementation of best practices.\n\nEthical considerations likely play a significant role in her practice. Maintaining patient confidentiality, upholding the principles of informed consent, and adhering to the highest standards of professional conduct are likely cornerstones of her approach. Her dedication to medical science also implies a commitment to rigorous methodology, transparency, and the responsible dissemination of research findings. In summary, Dr. Qadri's medical philosophy probably reflects a harmonious blend of compassion, scientific rigor, and ethical integrity, all aimed at providing the best possible care for her patients and advancing the field of medicine.\n\n### 3. Key Procedures & Clinical Expertise\n\nGiven the limited information on Dr. Qadri's specific practice, deducing her key procedures and clinical expertise requires drawing inferences from the L’Oréal-UNESCO Award. This prestigious award recognizes women scientists for their contributions to scientific progress, suggesting that her area of expertise lies within a research-intensive field. It is most likely that her expertise is not in performing common, routine, medical procedures, but rather in researching and developing novel approaches to treating or preventing diseases.\n\nThe L’Oréal-UNESCO Award spans various scientific disciplines, from life sciences to physical sciences. However, considering the medical context, her expertise would most likely fall under life sciences, potentially encompassing areas such as immunology, genetics, infectious diseases, or oncology. If her work is in immunology, her clinical expertise might revolve around understanding the complex interactions of the immune system and developing immunotherapies. In genetics, her expertise could involve gene therapy, personalized medicine based on genetic profiles, or the diagnosis and management of genetic disorders. In infectious diseases, she might specialize in developing new vaccines, diagnostic tools, or treatment strategies for emerging or drug-resistant infections. In oncology, her expertise could focus on targeted therapies, cancer prevention strategies, or personalized cancer treatment regimens.\n\nTherefore, while specific procedures are difficult to pinpoint, her clinical expertise likely lies in the application of cutting-edge scientific knowledge to address complex medical challenges. This could involve designing and conducting clinical trials, analyzing large datasets to identify biomarkers, developing novel diagnostic assays, or translating basic research findings into clinical applications. Her expertise would likely be highly sought after in academic medical centers, research institutions, and pharmaceutical companies.\n\n### 4. Academic Contributions & Research\n\nDr. Qadri's academic contributions and research are undoubtedly a defining aspect of her career, particularly given the recognition she has received through the L’Oréal-UNESCO Award. This award signifies that she has made significant and impactful contributions to her field of study. While the exact details of her publications and research projects remain unknown, it is possible to speculate on their nature and scope based on the award's criteria and the broader context of medical research.\n\nHer research focus areas most likely align with her clinical expertise. If, for instance, her expertise lies in infectious diseases, her research might focus on understanding the pathogenesis of specific infections, identifying novel drug targets, or developing innovative vaccine strategies. This could involve conducting laboratory experiments to investigate the molecular mechanisms of infection, analyzing clinical data to identify risk factors and predictors of disease outcome, or leading clinical trials to evaluate the safety and efficacy of new interventions.\n\nHer key publications would likely appear in high-impact, peer-reviewed journals within her field. These publications would be characterized by rigorous methodology, clear presentation of results, and insightful interpretation of findings. They would likely contribute to a deeper understanding of the disease process, inform clinical practice guidelines, or pave the way for the development of new therapies.\n\nThe impact of her research on medical science is likely substantial. Her findings may have led to improved diagnostic tools, more effective treatment strategies, or preventive measures that have reduced the burden of disease. She may have also mentored younger researchers and contributed to the training of the next generation of medical scientists. Furthermore, her work might have influenced public health policies, leading to improved access to healthcare and better health outcomes for vulnerable populations. Her research, therefore, likely extends beyond the laboratory and into the broader community, contributing to the advancement of medical knowledge and the improvement of human health.\n\n### 5. Patient Impact & Community Work\n\nWhile specific details regarding Dr. Qadri's direct patient interactions are limited, it's highly probable that her research and academic contributions have had a significant impact on patient outcomes, even if not directly in a clinical setting. Her research, if aimed at developing new treatments or diagnostic tools, would ultimately translate into improved care for patients suffering from the conditions she studies. For example, a novel vaccine developed through her research could prevent countless infections, while a new diagnostic test could lead to earlier and more accurate diagnoses, improving treatment outcomes.\n\nBeyond direct patient care, Dr. Qadri's community work likely extends to advocacy and education. She might be involved in raising awareness about the diseases she studies, promoting preventive measures, or advocating for policies that support medical research and improve access to healthcare. She may also participate in outreach programs to educate the public about scientific advancements and promote health literacy.\n\nFurthermore, her role as a mentor and educator likely contributes to a broader impact on patient care. By training and inspiring the next generation of medical professionals, she helps to ensure that future patients will receive high-quality, evidence-based care. Her influence, therefore, extends beyond individual patients to encompass the entire medical community and the population it serves.\n\n### 6. Legacy and Future Outlook\n\nDr. Firdausi Qadri's legacy is undoubtedly one of scientific excellence, dedication to patient well-being, and commitment to advancing medical knowledge. Her receipt of the L’Oréal-UNESCO Award solidifies her standing as a distinguished figure in the medical community, recognized for her groundbreaking research and its potential to improve human health.\n\nHer lasting influence will likely be felt through her publications, her contributions to clinical practice guidelines, and the impact of her research on patient outcomes. She will also be remembered as a role model for aspiring scientists, particularly women, inspiring them to pursue careers in medicine and research and to strive for excellence in their chosen fields.\n\nLooking ahead, Dr. Qadri's future outlook is bright. With her established track record of success, she is well-positioned to continue making significant contributions to medical science. She may pursue further research to refine existing treatments, develop new therapies, or address emerging health challenges. She may also take on leadership roles in academic institutions, research organizations, or public health agencies, further amplifying her impact on the medical community.\n\nHer legacy will be defined not only by her scientific achievements but also by her dedication to improving the lives of others. She stands as an example of how scientific rigor, compassion, and a commitment to innovation can transform medical practice and contribute to a healthier future for all.\n",
  "bioGenerated": true
}